Interplay of dopamine and GABA in substantia nigra for the regulation of rapid eye movement sleep in rats

被引:11
作者
Yadav, Raghunandan Kumar [1 ]
Khanday, Mudasir Ahmad [1 ,2 ]
Mallick, Birendra Nath [1 ]
机构
[1] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India
[2] Harvard Med Sch, Boston, MA 02115 USA
关键词
Chemical stimulation; Dopamine; GABA; Glutamate; REMS; Substantia nigra; REM-SLEEP; BRAIN-STEM; VISUAL HALLUCINATIONS; PARKINSONS-DISEASE; NEURONS; CONNECTIONS; MODULATION; TEGMENTUM; ACTIVATION; DEPRESSION;
D O I
10.1016/j.bbr.2019.112169
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Substantia nigra (SN) is rich in dopamine (DA)-ergic and GABA-ergic neurons, which project to and receive inputs from locus coeruleus (LC) and pedunculo-pontine tegmentum (PPT) possessing REM-OFF and REM-ON neurons, respectively. Loss of DA-ergic neurons and disturbed REM sleep (REMS) are associated with Parkinson's disease, depression and REMS behavior disorder. GABA-ergic projections from SN act pre-synaptically on the noradrenaline (NA)-ergic terminals coming from the LC-REM-OFF neurons onto the REM-ON neurons in PPT and play a critical role in initiating REMS. However, it was unknown how SN neurons get activated and whether the SN-DA-ergic neurons interact with the SN-GABA-ergic neurons for REMS regulation. In freely moving chronically prepared rats, neurons in SN (bilateral) were stimulated by local microinjection of Glutamate (Glut), sparing the fibers of passage, in the presence and absence of i.p. Haloperidol (Hal, DA-antagonist). In other sets, either Hal or Bicuculine (Bic, GABA-antagonist) alone or simultaneously was microinjected bilaterally into the SN and the effects on sleep-wakefulness were recorded. We observed that Glut in SN significantly increased REMS, which was prevented by Hal. REMS was decreased and increased by Hal and Bic, respectively; while their co-injection neutralized (ineffective) the individual effects. Combining these findings with previous reports suggest that the SN-DA-ergic neurons act on the SN-GABA-ergic to regulate REMS. The results advance our understanding of the neuro-anatomo-chemical connections and pharmaco-physiological regulation of REMS in health and diseases.
引用
收藏
页数:9
相关论文
共 46 条
[1]   MODULATION OF DENDRITIC RELEASE OF DOPAMINE BY N-METHYL-D-ASPARTATE RECEPTORS IN RAT SUBSTANTIA NIGRA [J].
ARANEDA, R ;
BUSTOS, G .
JOURNAL OF NEUROCHEMISTRY, 1989, 52 (03) :962-970
[2]   Hallucinations, REM sleep, and Parkinson's disease - A medical hypothesis [J].
Arnulf, I ;
Bonnet, AM ;
Damier, P ;
Bejjani, BP ;
Seilhean, D ;
Derenne, JP ;
Agid, Y .
NEUROLOGY, 2000, 55 (02) :281-288
[3]   Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons [J].
Beckstead, MJ ;
Grandy, DK ;
Wickman, K ;
Williams, JT .
NEURON, 2004, 42 (06) :939-946
[4]   EFFERENT CONNECTIONS OF THE SUBSTANTIA NIGRA AND VENTRAL TEGMENTAL AREA IN THE RAT [J].
BECKSTEAD, RM ;
DOMESICK, VB ;
NAUTA, WJH .
BRAIN RESEARCH, 1979, 175 (02) :191-217
[5]   ABUNDANT REM-SLEEP IN A PATIENT WITH ALZHEIMERS-DISEASE [J].
BLIWISE, DL ;
NINOMURCIA, G ;
FORNO, LS ;
VISESKUL, C .
NEUROLOGY, 1990, 40 (08) :1281-1284
[6]   A Perceptual Inference Mechanism for Hallucinations Linked to Striatal Dopamine [J].
Cassidy, Clifford M. ;
Balsam, Peter D. ;
Weinstein, Jodi J. ;
Rosengard, Rachel J. ;
Slifstein, Mark ;
Daw, Nathaniel D. ;
Abi-Dargham, Anissa ;
Horga, Guillermo .
CURRENT BIOLOGY, 2018, 28 (04) :503-+
[7]   Dopaminergic neurons [J].
Chinta, SJ ;
Andersen, JK .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2005, 37 (05) :942-946
[8]   PERIFORNICAL OREXINERGIC NEURONS MODULATE REM SLEEP BY INFLUENCING LOCUS COERULEUS NEURONS IN RATS [J].
Choudhary, R. C. ;
Khanday, M. A. ;
Mitra, A. ;
Mallick, B. N. .
NEUROSCIENCE, 2014, 279 :33-43
[9]   Sleep disorders in Parkinson's disease: An overview [J].
Comella, Cynthia L. .
MOVEMENT DISORDERS, 2007, 22 :S367-S373
[10]   The neurobiological characteristics of rapid eye movement (REM) sleep are candidate endophenotypes of depression, schizophrenia, mental retardation and dementia [J].
Gottesmann, Claude ;
Gottesman, Irving .
PROGRESS IN NEUROBIOLOGY, 2007, 81 (04) :237-250